A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Forian Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 100 shares of FORA stock, worth $225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$225
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.51 - $3.06 $43,264 - $52,745
17,237 New
17,237 $45,000
Q4 2023

Feb 14, 2024

BUY
$2.25 - $2.98 $22,295 - $29,528
9,909 New
9,909 $28,000
Q2 2023

Aug 14, 2023

SELL
$2.12 - $3.74 $12,654 - $22,324
-5,969 Reduced 33.18%
12,022 $29,000
Q1 2023

May 15, 2023

SELL
$2.29 - $5.2 $77,035 - $174,928
-33,640 Reduced 65.15%
17,991 $68,000
Q4 2022

Feb 14, 2023

BUY
$2.15 - $3.9 $73,373 - $133,095
34,127 Added 194.97%
51,631 $140,000
Q3 2022

Nov 14, 2022

SELL
$3.35 - $6.18 $107,059 - $197,500
-31,958 Reduced 64.61%
17,504 $59,000

Others Institutions Holding FORA

About Forian Inc.


  • Ticker FORA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 32,644,800
  • Market Cap $73.5M
  • Description
  • Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a...
More about FORA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.